2B70.DE vs. SLMC.DE
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE).
2B70.DE and SLMC.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. SLMC.DE is a passively managed fund by iShares that tracks the performance of the MSCI Europe ESG Screened. It was launched on Oct 19, 2018. Both 2B70.DE and SLMC.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 2B70.DE or SLMC.DE.
Key characteristics
| 2B70.DE | SLMC.DE | |
|---|---|---|
| YTD Return | 14.75% | 8.65% |
| 1Y Return | 31.27% | 16.99% |
| 3Y Return (Ann) | 2.58% | 4.70% |
| 5Y Return (Ann) | 8.13% | 7.32% |
| Sharpe Ratio | 1.87 | 1.52 |
| Sortino Ratio | 2.76 | 2.12 |
| Omega Ratio | 1.33 | 1.27 |
| Calmar Ratio | 1.23 | 2.16 |
| Martin Ratio | 8.57 | 9.03 |
| Ulcer Index | 3.59% | 1.76% |
| Daily Std Dev | 16.66% | 10.54% |
| Max Drawdown | -30.87% | -34.92% |
| Current Drawdown | -0.23% | -4.00% |
Correlation
The correlation between 2B70.DE and SLMC.DE is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
2B70.DE vs. SLMC.DE - Performance Comparison
In the year-to-date period, 2B70.DE achieves a 14.75% return, which is significantly higher than SLMC.DE's 8.65% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
2B70.DE vs. SLMC.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is higher than SLMC.DE's 0.12% expense ratio.
Risk-Adjusted Performance
2B70.DE vs. SLMC.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
2B70.DE vs. SLMC.DE - Dividend Comparison
Neither 2B70.DE nor SLMC.DE has paid dividends to shareholders.
Drawdowns
2B70.DE vs. SLMC.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum SLMC.DE drawdown of -34.92%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and SLMC.DE. For additional features, visit the drawdowns tool.
Volatility
2B70.DE vs. SLMC.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) (SLMC.DE) have volatilities of 3.90% and 4.07%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.